FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients

Abstract Background Epithelial ovarian cancer (EOC) is a spectrum of different diseases, which makes their treatment a challenge. Forkhead box M1 (FOXM1) is an oncogene aberrantly expressed in many solid cancers including serous EOC, but its role in non-serous EOCs remains undefined. We examined FOX...

詳細記述

書誌詳細

主要な著者:	Renata A. Tassi, Paola Todeschini, Eric R. Siegel, Stefano Calza, Paolo Cappella, Laura Ardighieri, Moris Cadei, Mattia Bugatti, Chiara Romani, Elisabetta Bandiera, Laura Zanotti, Laura Tassone, Donatella Guarino, Concetta Santonocito, Ettore D. Capoluongo, Luca Beltrame, Eugenio Erba, Sergio Marchini, Maurizio D’Incalci, Carla Donzelli, Alessandro D. Santin, Sergio Pecorelli, Enrico Sartori, Eliana Bignotti, Franco Odicino, Antonella Ravaggi
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2017-05-01
シリーズ:	Journal of Experimental & Clinical Cancer Research
主題:	Epithelial ovarian cancer Subtype Prognosis Chemoresistance FOXM1 Cell line
オンライン･アクセス:	http://link.springer.com/article/10.1186/s13046-017-0536-y
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!